1887

Journal of General Virology header logo

Volume 82, Issue 6

Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97 Free

Abstract

The UL97-encoded protein kinase (pUL97) of human cytomegalovirus (HCMV) plays a critical role in the control of virus replication. Deletion of the UL97 gene results in a drastic reduction in the replication efficiency. Although the exact function of pUL97 remains unclear and its sensitivity to specific inhibitors is speculative, protein kinase inhibitors of the indolocarbazole class are effective inhibitors of cytomegalovirus. Based on the phosphorylation of ganciclovir (GCV), a novel quantification system for pUL97 kinase activity was established: the phosphorylated form of GCV exerts an easily quantifiable cytotoxic effect in transfected cells. Importantly, the addition of indolocarbazole compounds, Gö6976 and NGIC-I, which were highly effective at nanomolar concentrations while other protein kinase inhibitors were not, led to a significant reduction of pUL97 kinase activity. It was also demonstrated that a catalytically inactive mutant of pUL97, K355M, and a GCV-resistant mutant, M460I, were both negative for GCV phosphorylation, although protein phosphorylation remained detectable for the latter mutant. kinase assays were used to confirm the levels of pUL97-mediated phosphorylation recorded. To generate a tool for screening large numbers of putative inhibitors that preferentially interfere with GCV as well as protein phosphorylation, pUL97-expressing cell clones with stable pUL97 kinase activity were selected. This study demonstrates that certain indolocarbazole compounds are potent pUL97 inhibitors and, therefore, represent novel candidates for antiviral drugs that target viral protein kinase functions.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-6-1439
2001-06-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/6/0821439a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-6-1439&mimeType=html&fmt=ahah

References

  1. Ansari A., Emery V. C. 1999; The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. Journal of Virology 73:3284–3291
     [Google Scholar]
  2. Beltinger C., Fulda S., Kammertoens T., Meyer E., Uckert W., Debatin K. M. 1999; Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proceedings of the National Academy of Sciences, USA 96:8699–8704
     [Google Scholar]
  3. Britt J. B., Alford C. A. 1996; Cytomegaloviruses. In Fields Virology pp 2493–2523 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  4. Cannon J. S., Hamzeh F., Moore S., Nicholas J., Ambinder R. F. 1999; Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. Journal of Virology 73:4786–4793
     [Google Scholar]
  5. Chee M. S., Lawrence G. L., Barrell B. G. 1989; Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. Journal of General Virology 70:1151–1160
     [Google Scholar]
  6. Chen M.-R., Chang S.-J., Huang H., Chen J.-Y. 2000; A protein kinase associated with Epstein–Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro . Journal of Virology 74:3093–3104
     [Google Scholar]
  7. Chulay J., Biron K., Wang L., Underwood M., Chamberlain S., Frick L., Good S., Davis M., Harvey R., Townsend L., Drach J., Koszalka G. 1999; Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease. Advances in Experimental Medicine and Biology 458:129–134
     [Google Scholar]
  8. Cunningham C., Davison A. J., Dolan A., Frame M. C., McGoech D. J., Meredith D. M., Moss H. W. M., Orr A. C. 1992; The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. Journal of General Virology 73:303–311
     [Google Scholar]
  9. Daikoku T., Shibata S., Goshima F., Oshima S., Tsurumi T., Yamada H., Yamashita Y., Nishiyama Y. 1997; Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2. Virology 235:82–93
     [Google Scholar]
  10. DeWind N., Domen J., Berns A. 1992; Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells. Journal of Virology 66:5200–5209
     [Google Scholar]
  11. Erice A. 1999; Resistance of human cytomegalovirus to antiviral drugs. Clinical Microbiology Reviews 12:286–297
     [Google Scholar]
  12. Freeman S. M., Abboud C. N., Whartenby K. A., Packman C. H., Koeplin D. S., Moolten F. L., Abraham G. N. 1993; The ‘bystander effect’: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Research 53:5274–5283
     [Google Scholar]
  13. Georgiev O., Bourquin J.-P., Gstaiger M., Knoepfel L., Schaffner W., Hovens C. 1996; Two versatile eukaryotic expression vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteins. Gene 168:165–167
     [Google Scholar]
  14. Goekjian P. G., Jirousek M. R. 1999; Protein kinase C in treatment of diseases: signal transduction pathways, inhibitors and agents in development. Current Medicinal Chemistry 6:877–903
     [Google Scholar]
  15. Hanson P. A., McLean T. I., Olgiate J., Hilton M., Miller W. E., Bachenheimer S. L. 1998; Herpes simplex virus type 1 induction of persistent NF-κB nuclear translocation increases the efficiency of virus replication. Virology 247:212–222
     [Google Scholar]
  16. Hayden F. G. 1995; Antiviral agents. In Principles and Practices of Infectious Diseases pp 411–450 Edited by Mandell G. L., Bennett J. E., Dolin R. New York: Churchill Livingstone;
     [Google Scholar]
  17. He Z., He Y. S., Kim Y., Chu L., Ohmstede C., Biron K. K., Coen D. M. 1997; The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. Journal of Virology 71:405–411
     [Google Scholar]
  18. Hu H. 1996; Recent discovery and development of selective protein kinase C inhibitors. Discovery Today 1:438–447
     [Google Scholar]
  19. Kawaguchi Y., van Sant C., Roizman B. 1998; Eukaryotic elongation factor 1δ is hyperphosphorylated by the protein kinase encoded by the UL13 gene of herpes simplex virus 1. Journal of Virology 72:1731–1763
     [Google Scholar]
  20. Kawaguchi Y., Matsumura T., Roizman B., Hirai K. 1999; Cellular elongation factor 1δ is modified in cells infected with representative alpha-, beta-, or gammaherpesviruses. Journal of Virology 73:4456–4460
     [Google Scholar]
  21. Kowalik T. F., Wing B., Haskill S., Azazkhan J., Baldwin A. S. Jr, Huang E.-S. 1993; Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proceedings of the National Academy of Sciences, USA 90:1107–1111
     [Google Scholar]
  22. Kunkel T. A. 1985; Rapid and efficient site-specific mutagenesis without phenotypic selection. Proceedings of the National Academy of Sciences, USA 82:488–492
     [Google Scholar]
  23. Littler E., Stuart A. D., Chee M. S. 1992; Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160–162
     [Google Scholar]
  24. Marschall M., Helten A., Hechtfischer A., Zach A., Banaschewski C., Hell W., Meier-Ewert H. 1999; The ORF regulated synthesis and persistence-specific variation of influenza C viral NS1 protein. Virology 253:208–218
     [Google Scholar]
  25. Marschall M., Freitag M., Weiler S., Sorg G., Stamminger T. 2000; Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrobial Agents and Chemotherapy 44:1588–1597
     [Google Scholar]
  26. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J. S., Freedman M., Cohen A., Gazit A., Levitzki A., Roifman C. M. 1996; Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 379:645–648
     [Google Scholar]
  27. Mhashilkar A. M., Biswas D. K., LaVecchio J., Pardde A. B., Marasco W. A. 1997; Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-tat single-chain intrabodies and NF-κB antagonists. Journal of Virology 71:6486–6494
     [Google Scholar]
  28. Michel D., Pavic I., Zimmermann A., Haupt E., Wunderlich K., Heuschmid M., Mertens T. 1996; The UL97 gene product of human cytomegalovirus is an early-late protein with nuclear localization but is not a nucleoside kinase. Journal of Virology 70:6340–6346
     [Google Scholar]
  29. Michel D., Schaarschmidt P., Wunderlich K., Heuschmid M., Simoncini L., Mühlberger D., Zimmermann A., Pavic I., Mertens T. 1998; Function regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself. Journal of General Virology 79:2105–2112
     [Google Scholar]
  30. Michel D., Kramer S., Höhn S., Schaarschmidt P., Wunderlich K., Mertens T. 1999; Amino acids of conserved kinase motifs of cytomegalovirus protein UL97 are essential for autophosphorylation. Journal of Virology 73:8898–8901
     [Google Scholar]
  31. Moffat J., Zerboni L., Sommer M. H., Heineman T. C., Cohen J. I., Kaneshima H., Arvin A. M. 1998; The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proceedings of the National Academy of Sciences, USA 95:11969–11974
     [Google Scholar]
  32. Ng T. I., Grose C. 1992; Serine protein kinase associated with varicella-zoster virus ORF 47. Virology 191:9–18
     [Google Scholar]
  33. Ng T. I., Keenan L., Kinchington R., Grose C. 1994; Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. Journal of Virology 68:1350–1359
     [Google Scholar]
  34. Ng T. I., Ogle W. O., Roizman B. 1998; UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 241:37–48
     [Google Scholar]
  35. Ogle W. O., Ng T. I., Carter K. L., Roizman B. 1997; The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0. Virology 235:406–413
     [Google Scholar]
  36. Oldfield E. H., Ram Z., Culver K. W., Blaese R. M., Devroom H. L., Anderson W. F. 1993; Gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Human Gene Therapy 4:36–39
     [Google Scholar]
  37. Perry C. M., Balfour J. A. B. 1999; Fomivirsen. Drugs 57:375–380
     [Google Scholar]
  38. Pindur U., Kim Y. S., Mehrabani F. 1999; Advances in indolo(2,3-a)carbazole chemistry: design and synthesis of protein kinase C and topoisomerase I inhibitors. Current Medical Chemistry 6:29–69
     [Google Scholar]
  39. Prichard M. N., Gao N., Jairath S., Mulamba G., Krosky P., Coen D. M., Parker B. O., Pari G. S. 1999; A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. Journal of Virology 73:5663–5670
     [Google Scholar]
  40. Purves F. C., Roizman B. 1992; The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein α22. Proceedings of the National Academy of Sciences, USA 89:7310–7314
     [Google Scholar]
  41. Quatsha K. A., Rudolph C., Marme D., Schächtele C., May W. S. 1993; Gö6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro . Proceedings of the National Academy of Sciences, USA 90:4674–4678
     [Google Scholar]
  42. Slater M. J., Cockerill S., Baxter R., Bonser R. W., Gohil K., Gowrie C., Robinson J. E., Littler E., Parry N., Randall R., Snowden W. 1999; Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication. Bioorganic & Medicinal Chemistry Letters 7:1067–1074
     [Google Scholar]
  43. Smith R. F., Smith T. F. 1989; Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein–Barr virus. Journal of Virology 63:450–455
     [Google Scholar]
  44. Sullivan V., Talarico C. L., Stanat S. C., Davis M., Coen D. M., Biron K. K. 1992; A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358:162–164
     [Google Scholar]
  45. van Zeijl M., Fairhurst J., Baum E. Z., Sun L., Jones T. R. 1997; The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 231:72–80
     [Google Scholar]
  46. Waldman W. J., Knight D. A., Lurain N. S., Miller D. M., Sedmak D. D., Williams J. W., Chong A. S.-F. 1999a; Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation 68:814–826
     [Google Scholar]
  47. Waldman W. J., Knight D. A., Blinder L., Lurain N. S., Miller D. M., Sedmak D. D., Williams J. W., Chong A. S.-F. 1999b; Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 42:412–418
     [Google Scholar]
  48. Wolf D. G., Honigman A., Lazarovits J., Tavor E., Panet A. 1998; Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase. Archives of Virology 143:1223–1232
     [Google Scholar]
  49. Yurochko A. D., Kowalik T. F., Huong S.-M., Huang E.-S. 1995; Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. Journal of Virology 69:5391–5400
     [Google Scholar]
  50. Yurochko A. D., Hwang E.-S., Rasmussen L., Keay S., Pereira L., Huang E.-S. 1997; The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. Journal of Virology 71:5051–5059
     [Google Scholar]
  51. Zimmermann A., Wilts H., Lenhardt M., Hahn M., Mertens T. 2000; Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase. Antiviral Research 48:49–60
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-6-1439
Loading
Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97
J. Gen. Virol. 82, 1439 (2001); https://doi.org/10.1099/0022-1317-82-6-1439
/content/journal/jgv/10.1099/0022-1317-82-6-1439
/content/journal/jgv/10.1099/0022-1317-82-6-1439
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error